Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardinal Health's Ending Cash Position for the quarter that ended in Mar. 2026 was $3,937 Mil.
Cardinal Health's quarterly Ending Cash Position
declined
from Sep. 2025 ($4,593 Mil) to Dec. 2025 ($2,777 Mil) but then
increased
from Dec. 2025 ($2,777 Mil) to Mar. 2026 ($3,937 Mil).
Cardinal Health's annual Ending Cash Position
increased
from Jun. 2023 ($4,076 Mil) to Jun. 2024 ($5,133 Mil) but then
declined
from Jun. 2024 ($5,133 Mil) to Jun. 2025 ($3,874 Mil).
Cardinal Health Ending Cash Position Related Terms
Cardinal Health Ending Cash Position Historical Data
* Premium members only.
The historical data trend for Cardinal Health's Ending Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.
Cardinal Health's Ending Cash Position for the fiscal year that ended in Jun. 2025 is calculated as
What does a Ending Cash Position of $3,937 Mil mean?
Cardinal Health (LTS:0HTG) has a Ending Cash Position of $3,937 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Cardinal Health and its competitors.
Is Cardinal Health's Ending Cash Position too high?
Cardinal Health's current Ending Cash Position is $3,937 Mil. Overall, Cardinal Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's Ending Cash Position compare to COR and MCK?
Cardinal Health's Ending Cash Position of $3,937 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Distribution company?
A good Ending Cash Position depends on the Medical Distribution industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Cardinal Health and its competitors. Cardinal Health's current Ending Cash Position is $3,937 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (LTS:0HTG) is currently considered Significantly Overvalued. The stock's GF Value™ is $142.03, compared to a current price of $227.41 — trading 60.1% above its estimated fair value. The current Ending Cash Position is $3,937 Mil. Cardinal Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Cardinal Health (LTS:0HTG), the current Ending Cash Position is $3,937 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardinal Health (LTS:0HTG) Overvalued in 2026?
Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued.
The current stock price of $227.41 is trading 60.1% above its estimated GF Value™ of $142.03.
GuruFocus considers Cardinal Health to be Significantly Overvalued.
Key valuation signals for LTS:0HTG:
Ending Cash Position: $3,937 Mil
GF Value™: $142.03 vs. price of $227.41 (60.1% above fair value)
No single metric tells the full story. See the LTS:0HTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
81GF Score
Get the complete analysis for LTS:0HTG
Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0HTG has been successfully added to your 
